Digital Pharma

2018년 9월 19-20일 • 싱가포르

개요

디지털 혁명은 다양한 사업 분야에서 파괴적인 변화를 일으키고 있으며, 제약업계도 예외가 아닙니다. Digital Pharma Summit에서는 세계 제약업계의 기술면 전망, 새로운 동향, 혁신적인 도입 전략, 투자, 디지털화 프로젝트의 사례 연구 등 다양한 토픽에 관한 논의가 진행됩니다.

IBC가 주최하는 제5회 PharmaCon Asia 2018의 일부를 담당하는 이 서밋은 아시아 지역의 제약업계에 참여하고 있는 전문가가 한자리에 모이는 중요 이벤트입니다. 컨퍼런스에서는 임상시험, 시장 진출, 제약업계의 디지털화, 법령 준수 원칙 등의 토픽이 다루어지며, 의약품 개발과 상업화에 관련된 밸류체인의 모든 영역에 초점을 맞춥니다.

컨퍼런스 하이라이트

  • 제약업계의 디지털화를 테마로 한 아시아 지역 유일의 이벤트로, 디지털 전환의 영향을 받고 있는 다양한 기업의 사례 연구 소개
  • 아시아뿐만 아니라 세계 각 지역에서 디지털 전환에 참여하고 있는 전문가와의 네트워킹, 제약업계에 관한 견해 청취
  • 기술면의 전망 및 제약업계에 대한 영향 등 소개
  • 기술면의 최신 동향 및 디지털 기술의 진보에 스포트라이트
  • 제약업계 에코시스템의 새로운 비지니스 모델 및 혁신적 제휴에 대해 분석
  • 디지털화에서 주목받고 있는 제약회사의 최신 정보 소개

동시 개최 이벤트

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Summit >>
Pharma Market Access and Pricing Summit Asia >>

 

아젠다

8:00 am

Registration and Networking Session

PHARMACON ASIA OPENING PLENARY SESSION

9:00 am

Addressing on skilled talent, strong manufacturing capabilities and thriving research ecosystem in pharmaceutical firms to set up to serve patients and connect with the growing Asian market

9:30 am

[Industry Address] Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines

Nik Leist, Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

10:40 am

Morning Networking and Refreshment Break

DIGITAL PHARMA SUMMIT COMMENCES

11:10 am

Digital Pharma Chairman's Opening Remarks

TRENDS IN DIGITALISATION

11:15 am

CIO Interview: Progressing Digital Transformation in Pharma

Bruce Shi, Chief Information Officer, Asia, Sanofi, Singapore

11:45 am

  • Snapshots on tech trends that are gaining traction
  • Where are digital investments going?
  • How can pharmaceutical companies leverage them in compliance with stringent regulations
  • New regulatory framework to build trusted algorithms

CIO Interview: Progressing Digital Transformation in Pharma

Bruce Shi, Chief Information Officer, Asia, Sanofi, Singapore

REDEFINING PHARMA - CONSUMER INTERACTIONS

1:00 pm

Networking Lunch

2:00 pm

  • Importance of staying engaged with consumers/patients
  • Preparing for disruption
  • Why MNCs are at risk of disruptions

2:30 pm

Developing Innovative Technological Solutions to Improve Patient Outcomes

Aaron Tian, Head of Neuroscience Patient Innovation, UCB, China

3:00 pm

Tech Showcase: Strategies to Seamlessly Integrated and Personalised Customer Experience and Patients Outcomes Online and Offline

3:30 pm

Afternoon Networking

4:00 pm

  • How can digitalisation and connected world play the part in monitoring better patient outcomes, drug performance and market dynamics of approved drugs?
  • How is the deployment of smartphone seen as 'an access to global knowledge powered by AI in anyone's hand'
  • How can it trigger a revolution in pharmacovigilance and risk minimisation?
  • Case studies to elaborate on the need for a versatile app to enforce educational risk minimization

4:30 pm

  • The rise of apps as medical devices
  • The convergence between tech and pharma
  • How artificial intelligence will make healthcare more efficient

REGIONAL TRENDS IN PHARMA 4.0

5:00 pm

  • 100 Experiments (100E) programme
  • How the Pharma industry is benefiting
  • Use cases of how AI is applied in the Pharma industry

5:30 pm

  • Examining the current impact of digitalisation in the Asian Pharma sector
  • What touch points will have most influence
  • How is Pharma – HCP - Patient engagement going to change
  • Pharma and Consumer interface evolution
  • What is needed to give Pharma a digital boost

6:00 pm

End of Conference Day 1, followed by networking cocktails

8:55 am

Morning Coffee

PHARMA - HCP RELATIONSHIPS

9:00 am

Digitalising Pharma - HCP Engagement: Challenges, Opportunities and Benefits

Julie Olszewski, Executive Director, MSD Global Innovation Hub, MSD, Singapore

9:30 am

  • Patient journey and their experience with medication is changing with the increasing pervasiveness of digital and mobile communication platform
  • Addressing technological advancement such as cloud, IoT, data analytics and AI
  • Medical doctors' experience on rapid change and transformation from the impact of technology
  • How can patients, doctors and pharma find the convergence and success in digital solutions and what good (experience) looks like?

BEYOND THE PILL

10:00 am

Digital Pharma and Precision Medicine in the Age of Data Science, Machine Learning and Real Time Analytics

Yaron Turpaz, Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

10:30 am

Morning Networking and Refreshment Break

11:00 am

  • Trends of digital innovations in Pharma & Healthcare
  • Challenges in adapting digitalization in these fields
  • How digitalization will help to create value chain for the patients

11:30 am

Use & Perception of Scientific Medical Reprints and Opportunities in Digital Marketing

Amit Singh, Director - Pharma Business, Elsevier, India

12:00 pm

  • Overview of emerging trends in medical technologies, and extrapolation to future business opportunities for digital pharma
  • Direct-to-consumer distribution and supply chain optimisation

12:30 pm

Networking Lunch

1:30 pm

Case Study: Preventing the Risk of Cardiovascular Disease via a Doctor - Patient - Consumer Digital Platform

Dr. Peter Ting, Co-Founder, Cardiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital, Singapore

2:00 pm

The Impact of Technology in Reshaping the Thinking of Pharma Leaders - Transformation, Investments, Business Strategies

Tamsin Greulich-Smith, Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of Singapore, Singapore

ENABLING DIGITALISATION

2:30 pm

  • Starting out on analytics journeys - common starting points that set you up for failure
  • Problems with process - 'right governance wrong place' processes that set analytics up to fail
  • Metric malfunction - how managing an analytics department can look right on paper but still be worthless
  • 3 big ideas that will help you avoid these pitfalls and get real value from analytics

3:00 pm

  • Will this be a barrier for pharma companies to digitally transform?
  • How can traditional practices be seamlessly transform to accommodate to the digital age's needs?

3:30 pm

Afternoon Networking

CLOSING PLENARY SESSION

5:00 pm

Chairperson's Summary of the Day and End of Conference

* 주최사의 사정에 의해 사전예고 없이 프로그램이 변경될 수 있습니다.

연사

Ho Weng Si

Director, Biomedical Sciences Group, Economic Development Board, Singapore

Nik Leist

Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Serlin

Asia Cluster Head, Novartis

Miguel Angel Rivera Tapia

Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

How Ti-Hwei

Country President, AstraZeneca, Singapore

Bruce Shi

Chief Information Officer, Asia, Sanofi, Singapore

Amkidit Afable

Director Go-To-Market, Johnson & Johnson, Singapore

Aaron Tian

Head of Neuroscience Patient Innovation, UCB, China

Jean-Christophe Delumeau

Head of Pharmacovigilance Policy Strategy, Bayer, Singapore

Laurence Liew

Director, AI Singapore, Singapore

Prabhuram Krishnan

Medical Director (South Asia - Hong Kong, ASEAN, India), Ipsen, Singapore

Rafiqul Islam

IT Head-ADC Asia Pac, IT Business Relationship, Abbott Laboratories, Singapore

Jason Tamara Widjaja

Associate Director, Global Data Science (AI & Data Products), MSD, Singapore

Julie Olszewski

Executive Director, MSD Global Innovation Hub, MSD, Singapore

Paul Tan

Director, KPMG Healthcare & Life Sciences, Singapore

Yaron Turpaz

Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

Mrunalini Jagtap

Data Management Lead, Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore

Amit Singh

Director - Pharma Business, Elsevier, India

Dr. Dinesh Visva Gunaskeran

Steering Committee (Head, Big Data Protocol), Collaborative Ocular Tuberculosis Study, Singapore

Dr. Peter Ting

Co-Founder, Cardiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital, Singapore

Tamsin Greulich-Smith

Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of Singapore, Singapore

Winston Chew

Director, Regional Information Security Officer, GlaxoSmithKline, Singapore

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Harish Dave

Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

개최 기간 및 개최지

2018년 9월 19-20일

싱가포르
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

메일링 서비스
메일링 서비스